Skip to content

Oral alpha-ketoglutarate for treating cyanide poisoning

A phase-II open labeled, comparative, field study to assess efficacy of oral sodium alpha-ketoglutarate in treating cyanide poisoning

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2013/01/003331
Enrollment
1000
Registered
2013-01-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Suspected or confirmed victims of cyanide poisoning/ terrorism, or Rescue workers exposed to or suspected to have been exposed to cyanide, including hydrogen cyanide

Interventions

Intervention1: Disodium alpha-ketoglutarate: Disodium alpha-ketoglutarate 20 grams dispensed as powder in 5/10 gram sachets to be taken orally with water or as preformed solution to be drunk from a bo

Sponsors

Defence Research and Development Organisation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The study shall include: a) Suspected or confirmed victims of isolated cyanide poisoning; b) Suspected or confirmed victims of cyanide terrorism; c) Rescue workers exposed to or suspected to have been exposed to cyanide, including hydrogen cyanide

Exclusion criteria

Exclusion criteria: Following human subjects will be excluded from the study: a) Uncontrolled vomiting b) Altered sensorium where oral administration is impossible and Ryles intubation not available c)Where conventional medical treatment is available and the medical team decides in favor of conventional treatment only. d) Subject / caretaker refusal (in case of patient being in Coma) e) Patients who have any medical condition which in the judgment of the investigator may render them inappropriate for participation in the trial

Design outcomes

Secondary

MeasureTime frame
Reduction in cyanide induced toxicity symptoms with respect to parameters mentioned below:Timepoint: a) Level of consciousness b) Reversal of respiratory distress c) Betterment of arousal state d) Comparison between amount of life-support or supportive care needed at hospital in the two groups

Primary

MeasureTime frame
Reduction in mortality and severity of morbidity due to cyanide poisoningTimepoint: Reduction in mortality and severity of morbidity due to cyanide poisoning

Countries

India

Contacts

Public ContactAseem Bhatnagar

Defence Research and Development Organisation

dr.aseembhatnagar@gmail.com23905172

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026